Nippon India Pharma Fund (Bonus) Equity - Pharma
Plan: OPEN | Option: Growth | Sailesh Raj Bhan
06 May 25 | 12:00 AM
492.45 -4.69 (-0.94%)
Critical Parameters
Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.
Returns
In last 1 year Nippon India Pharma Fund (Bonus), has underperformed by -32.85% (CAGR difference)
15.47%
Underperforms
This is Alpha
Performance Chart for Rs
Invested in
07 May 2024
Risk
In last 1 year , the volatility of Nippon India Pharma Fund (Bonus) is Lower than by -0.50%
0.96%
Less Volatile
Risk Meter
Consistency
For out of Last 0 Months, i.e 0% of the times It underperformed its benchmark, Equity - Pharma
Consistency Meter
Outperforming Stocks Vs. Underperforming Stocks
Based on the last 1year analysis, currently there are, 16 Stocks beating the benchmark 18 Stocks not beating the benchmark
